1. Cimzia is an injection for patients with nonradiographic axial spondyloarthritis, a specific inflammatory arthritis. It is the first treatment for the specific type of arthritis.
2. Jatenzo is an oral testosterone capsule to treat hypogonadism, a condition in which the body doesn’t produce enough testosterone.
3. Mayzent is approved to treat patients with relapsing forms of multiple sclerosis.
4. Ambrisentan, manufactured by Zydus Cadila, is used to treat pulmonary hypertension, or high blood pressure in the lungs.
More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
